A Hochberg

906 total citations
19 papers, 765 citations indexed

About

A Hochberg is a scholar working on Genetics, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, A Hochberg has authored 19 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 9 papers in Molecular Biology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in A Hochberg's work include Genetic Syndromes and Imprinting (8 papers), Prenatal Screening and Diagnostics (5 papers) and Gestational Trophoblastic Disease Studies (5 papers). A Hochberg is often cited by papers focused on Genetic Syndromes and Imprinting (8 papers), Prenatal Screening and Diagnostics (5 papers) and Gestational Trophoblastic Disease Studies (5 papers). A Hochberg collaborates with scholars based in Israel, United States and Germany. A Hochberg's co-authors include Natalia Sánchez de Groot, Tamar Schneider, I M Ariel, N DEGROOT, Patricia Ohana, I. Ariel, Volker A. Erdmann, Suhail Ayesh, Abraham Czerniak and Michael Elkin and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Oncogene.

In The Last Decade

A Hochberg

19 papers receiving 754 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Hochberg Israel 13 487 292 182 99 92 19 765
Gufeng Xu China 12 313 0.6× 178 0.6× 40 0.2× 71 0.7× 84 0.9× 40 628
Chi‐Mu Chuang Taiwan 13 386 0.8× 313 1.1× 43 0.2× 14 0.1× 185 2.0× 19 801
Lauren R Zeitels United States 7 482 1.0× 370 1.3× 133 0.7× 15 0.2× 84 0.9× 7 828
Yanlin Huang China 16 443 0.9× 219 0.8× 42 0.2× 31 0.3× 151 1.6× 64 815
Tatiana Sedláčková Slovakia 14 319 0.7× 264 0.9× 42 0.2× 32 0.3× 260 2.8× 39 623
K Nanbu Japan 9 359 0.7× 105 0.4× 77 0.4× 6 0.1× 102 1.1× 11 670
G F Saunders United States 9 578 1.2× 31 0.1× 191 1.0× 77 0.8× 67 0.7× 10 741
Phillip Koeffler United States 11 277 0.6× 48 0.2× 79 0.4× 10 0.1× 95 1.0× 22 599
Yunping Lu China 10 258 0.5× 124 0.4× 68 0.4× 7 0.1× 117 1.3× 31 503

Countries citing papers authored by A Hochberg

Since Specialization
Citations

This map shows the geographic impact of A Hochberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Hochberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Hochberg more than expected).

Fields of papers citing papers by A Hochberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Hochberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Hochberg. The network helps show where A Hochberg may publish in the future.

Co-authorship network of co-authors of A Hochberg

This figure shows the co-authorship network connecting the top 25 collaborators of A Hochberg. A scholar is included among the top collaborators of A Hochberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Hochberg. A Hochberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hanna, Nader, Patricia Ohana, Fred M. Konikoff, et al.. (2012). Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer. Cancer Gene Therapy. 19(6). 374–381. 113 indexed citations
2.
Mader, Robert M., et al.. (2011). Suicide activation in a 5-fluorouracil resistant colon cancer model in vitro.. PubMed. 49(1). 69–70. 7 indexed citations
3.
Sorin, Vladimir, Yakov Fellig, Tatiana Birman, et al.. (2010). Use of H19 Gene Regulatory Sequences in DNA-Based Therapy for Pancreatic Cancer. Journal of Oncology. 2010. 1–10. 52 indexed citations
4.
Tanos, Vasilios, Irving M. Ariel, Diana Prus, N DEGROOT, & A Hochberg. (2004). H19 and IGF2 gene expression in human normal, hyperplastic, and malignant endometrium. International Journal of Gynecological Cancer. 14(3). 521–525. 8 indexed citations
5.
Ayesh, Basim M., Imad Matouk, Patricia Ohana, et al.. (2003). Inhibition of tumor growth by DT-A expressed under the control of IGF2 P3 and P4 promoter sequences. Molecular Therapy. 7(4). 535–541. 20 indexed citations
6.
Goshen, Ran, Bernard Gonik, Ilana Ariel, et al.. (1999). High Levels of Maternal Serum Human Chorionic Gonadotropin in Down Syndrome Pregnancies: The Possible Role of a Transcription Factor on Chromosome 21. Fetal Diagnosis and Therapy. 14(2). 106–111. 8 indexed citations
7.
Elkin, Michael, Irving M. Ariel, Adi Nagler, et al.. (1999). Inhibition of bladder carcinoma angiogenesis, stromal support, and tumor growth by halofuginone.. PubMed. 59(16). 4111–8. 79 indexed citations
8.
Erdmann, Volker A., M. Szymański, A Hochberg, Natalia Sánchez de Groot, & Jan Barciszewski. (1999). Collection of mRNA-like non-coding RNAs. Nucleic Acids Research. 27(1). 192–195. 54 indexed citations
9.
Kopf, Eliezer, Suhail Ayesh, Mark L. Tykocinski, et al.. (1998). The effect of retinoic acid on the activation of the human H19 promoter by a 3′ downstream region. FEBS Letters. 432(3). 123–127. 12 indexed citations
10.
Ariel, I., A Hochberg, & Mara Shochina. (1998). Endothelial nitric oxide synthase immunoreactivity in early gestation and in trophoblastic disease.. Journal of Clinical Pathology. 51(6). 427–431. 46 indexed citations
11.
Ariel, I M, Hui Miao, Tamar Schneider, et al.. (1998). Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma.. Molecular Pathology. 51(1). 21–25. 108 indexed citations
12.
Schulze, Ekkehard, D. Komitowski, Volker A. Erdmann, et al.. (1997). The expression of the imprinted genes H19 and IGF-2 in choriocarcinoma cell lines. Is H19 a tumor suppressor gene?. Oncogene. 15(2). 169–177. 48 indexed citations
13.
Goshen, Ran, et al.. (1996). Hyaluronan, CD44 and its variant exons in human trophoblast invasion and placental angiogenesis. Molecular Human Reproduction. 2(9). 685–691. 44 indexed citations
14.
Rachmilewitz, Jacob, Michael Elkin, Leendert H. J. Looijenga, et al.. (1996). Characterization of the imprinted IPW gene: allelic expression in normal and tumorigenic human tissues.. PubMed. 13(8). 1687–92. 19 indexed citations
15.
Ariel, I M, et al.. (1995). The imprinted H19 gene as a tumor marker in bladder carcinoma. Urology. 45(2). 335–338. 86 indexed citations
16.
Ariel, I., Calvin E. Oyer, Michael Elkin, et al.. (1994). Relaxation of Imprinting in Trophoblastic Disease. Gynecologic Oncology. 53(2). 212–219. 44 indexed citations
17.
Lorberboum‐Galski, Haya, Shai Yarkoni, Amotz Nechushtan, et al.. (1994). ABL and BCR Genes Are Not Imprinted in Androgenetic and Gynogenetic Human Tissues. Biochemical and Biophysical Research Communications. 204(2). 621–627. 2 indexed citations
18.
Rachmilewitz, Jacob, Bernard Gonik, Ran Goshen, et al.. (1993). Use of a Novel System for Defining a Gene Imprinting Region. Biochemical and Biophysical Research Communications. 196(2). 659–664. 5 indexed citations
19.
Johansson, Hans E., Natalia Sánchez de Groot, A Hochberg, & Matthias W. Hentze. (1991). Effect of heparin contained in preparations of small cytoplasmic RNAs on cell-free translation. Journal of Biological Chemistry. 266(3). 1921–1925. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026